A STUDY ON AYURVEDA MEDICINES - MISHREYA CHOORNA (FENNEL POWDER) AND ASHWAGANDHA CHOORNA(Powdered root of WITHANIA SOMNIFERA) IN MENTAL SYMPTOMS OF PREMENSTRUAL SYNDROME.
Not yet recruiting
- Conditions
- Premenstrual tension syndrome,
- Registration Number
- CTRI/2019/09/021241
- Lead Sponsor
- Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
- Brief Summary
This study is an open label, double arm, exploratoryclinical study comparing the efficacy of Mishreya choorna 3gmBD daily andAshwagandha choorna 3gm BD daily for three months in 40 patients with Premenstrual syndrome. The study is conducted in Hospital attachedto Ayurveda medical college with laboratory facilities. The primary outcomemeasure reduction in Premenstrual Syndrome score after 90 days of trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- 1.Female subjects with regular menstrual cycle since 3 months.
- 2.Age between 18 years of age to 40 years of age irrespective of socio economic status and in good medical health.
- 3.The subjects who are ready to follow the treatment protocol and sign the informed consent form.
Exclusion Criteria
- 1.Those with symptoms existing less than three cycles.
- 2.Subjects having diabetes mellitus, hypertension, PCOS, DUB.
- 3.Subjects suffering from other acute and chronic psychiatric illnesses 4.Subjects suffering from organic brain diseases.
- 5.Subjects under hormonal and psychiatric treatment.
- 6.Subjects taking Oral Contraceptive Pills.
- 7.Subjects with Premenstrual Dysphoric disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EFFECT OF MISHREYA CHOORNA IN COMPARISON TO ASHWAGANDHA CHOORNA IN PSYCHOLOGICAL SYMPTOMS OF PREMENSTRUAL SYNDROME 3 MONTHS
- Secondary Outcome Measures
Name Time Method Reduction in Somatic symptoms of premenstrual syndrome. 90 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Mishreya choorna and Ashwagandha choorna in premenstrual syndrome?
How do Ayurvedic treatments like Mishreya and Ashwagandha choorna compare to SSRIs in managing premenstrual psychological symptoms?
Are there specific biomarkers that predict response to Mishreya or Ashwagandha choorna in premenstrual tension syndrome?
What are the potential adverse events associated with long-term use of Mishreya and Ashwagandha choorna in PMS patients?
What combination therapies involving Ayurvedic compounds show promise in treating premenstrual syndrome?
Trial Locations
- Locations (1)
Sri Dharmasthala Manjunatheshwara Ayurveda hospital
🇮🇳Hassan, KARNATAKA, India
Sri Dharmasthala Manjunatheshwara Ayurveda hospital🇮🇳Hassan, KARNATAKA, IndiaDr Saumyalakshmi SPrincipal investigator08217486934drsoumyalakshmi@gmail.com